KIM LLC’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

KIM LLC’s Portfolio EBAC Stock Details EBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-200,000	Closed	-$2.02M	–	656
2022 Q4	$2.02M	Hold	200,000	–	–	0.11%	221
2022 Q3	$1.98M	Hold	200,000	–	–	0.09%	275
2022 Q2	$1.96M	Buy	+200,000	New	+$1.96M	0.09%	291

KIM LLC's EBAC Position: Q1 2023 in Review

KIM LLC sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q1 2023, closing a stake of 200,000 shares — an estimated $2.02M sold.

KIM LLC first reported a position in EBAC in Q2 2022 and held it in 3 quarters. The position peaked at $2.02M in Q4 2022. 0 funds tracked by Wall St. Rank hold EBAC as of Q1 2023.

KIM LLC reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
KIM LLC sold 200,000 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $2.02M.
KIM LLC first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q2 2022 and held it in 3 quarters.
KIM LLC's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $2.02M in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on KIM LLC's 13F filing for Q1 2023, filed 11 May 2023.